ASPC (@ASPCardio) - Twitter Profili | Zamantika Mersobahis Locabet

Sabitlenmiş Tweet

ASPC@ASPCardio·24 Mar

Registration is now open for the ASPC 2026 Congress on Cardiovascular Disease Prevention 🎓 Join leading experts in preventive cardiology for 2.5 days of cutting-edge science, clinical insights, and real-world application—all focused on advancing care for patients at risk of cardiovascular disease. 📍 Scottsdale, AZ 📅 July 31 – August 2, 2026 From innovative research and expert-led sessions to networking and collaboration, this is where the future of prevention takes shape. 👉 Register now: aspconline.org/events/2026con… #Cardiology #PreventiveCardiology #CME #MedicalEducation #HeartHealth @AJPCardio

English

0

11

23

3.2K

ASPC retweetledi

AJPC@AJPCardio·10h

Can where we spend time outdoors influence heart health? 🌳❤️ A new study examining mobility data across nine major U.S. metropolitan areas found that greater neighborhood green space visitation was associated with lower coronary heart disease (CHD) prevalence in several cities, including Houston, Atlanta, Chicago, Dallas, and Phoenix. The findings suggest that engagement with green spaces—not just their presence—may play an important role in cardiovascular health. Researchers used mobility-derived data to better understand how real-world interaction with parks and green environments relates to cardiovascular disease patterns across diverse urban settings. The study also highlights important geographic differences, with stronger associations observed in many suburban neighborhoods and areas with elevated metabolic risk. As cardiovascular prevention continues to expand beyond traditional risk factors, studies like this reinforce the importance of the built environment, public health infrastructure, and equitable access to healthy spaces. Read the article here: sciencedirect.com/science/articl… #Cardiology #PreventiveCardiology #PublicHealth #HeartHealth #UrbanHealth #Greenspace #CardiovascularHealth #Research

English

2

3

9

321

ASPC retweetledi

National Triglyceride Alliance@NatTgAlliance·1d

Triglycerides are no longer a footnote in cardiovascular risk management. Module 4 of our clinician education series equips you with the science and clinical tools to move beyond LDL-centric thinking — covering TG biology, remnant lipoprotein pathways, ApoC-III–mediated mechanisms, and a phenotype-driven approach to hypertriglyceridemia management. What’s inside: 🔬 TG metabolism under physiologic and pathologic conditions 📊 Clinical trial evidence on legacy therapies — and their limitations 💡 Emerging treatment strategies targeting residual cardiovascular risk and pancreatitis prevention 🩺 A framework for applying trial evidence at the point of care Elevate your practice. Watch here: nationaltriglyceridealliance.com/educational-mo… #ClinicalEducation #Lipidology #Triglycerides #pancreatitis

National Triglyceride Alliance tweet media

English

0

2

5

241

ASPC@ASPCardio·1d

New research highlights a promising noninvasive window into women’s heart health. 👁️❤️ A pilot study found that retinal OCTA imaging detected microvascular remodeling associated with coronary microvascular dysfunction (CMD) in women with ischemia and no obstructive coronary artery disease (INOCA). Women with CMD showed significantly lower retinal vessel and perfusion density, reinforcing the concept that the eye may offer important clues about systemic vascular health. These findings support the growing role of “oculomics” and retinal imaging as accessible tools for cardiovascular risk assessment and early detection. Excited to see where this research leads next. Read the study here: sciencedirect.com/science/articl… #Cardiology #WomenInMedicine #CardiovascularHealth #Research #PrecisionMedicine

English

1

9

15

1.6K

ASPC@ASPCardio·4d

Now available on demand: a practical review of the new 2026 ACC/AHA Multi-Society Dyslipidemia Guideline with @rblument1, MD, FASPC, moderated by @AshishSarraju, MD. This CardioCore Foundational Lecture covers: ✔️ Contemporary cardiovascular risk assessment ✔️ Individualized lipid-lowering therapy strategies ✔️ Updated LDL-C, non–HDL-C, and ApoB targets ✔️ The role of Lp(a) and coronary artery calcium (CAC) ✔️ Triglyceride management for ASCVD and pancreatitis risk ✔️ Evidence-based care for high-risk populations, including diabetes and CKD Watch now: youtube.com/watch?v=PJmBvG…

YouTube

English

0

4

13

480

ASPC retweetledi

National Triglyceride Alliance@NatTgAlliance·14 May

📘 New Educational Module Available: Hypertriglyceridemia & Emerging TG-Lowering Therapies Module #4 from the National Triglyceride Alliance, hosted by @mmillermd1, explores the evolving science of triglycerides (TG), cardiovascular risk, and the next generation of TG-lowering therapies. Learners will gain insights into: 🔹 The spectrum of hypertriglyceridemia and its links to ASCVD, pancreatitis, and cardiometabolic disease 🔹 TG metabolism, remnant lipoproteins, and ApoC-III pathways 🔹 Major clinical trial data on traditional TG-lowering therapies and their limitations 🔹 Emerging therapies targeting residual cardiovascular risk and pancreatitis prevention By the end of the module, participants will be equipped to apply a phenotype-driven approach to hypertriglyceridemia management and integrate novel treatment strategies into clinical practice. Explore the module here 👇 nationaltriglyceridealliance.com/educational-mo… @SethJBaumMD @EliotBrinton @lipiddoc @ArchnaBajajMD @drmaggarwal @nationallipid @foundationofnla @ASPCardio @NatPancFdn @livingwithfcs @TheAACE @HeartNurses @ionispharma @ArrowheadPharma @Amarincorp #Hypertriglyceridemia #Triglycerides #PreventiveCardiology #CardiologyEducation #LipidManagement #CardiometabolicHealth #MedicalEducation #NationalTriglycerideAlliance

English

0

4

7

450

ASPC@ASPCardio·14 May

⏰ Happening NOW! CardioCore: Lipid Guidelines 📅 Today | 6:00–7:00 PM EDT 🎓 Lecturer: @rblument1Join ASPC for a FREE webinar translating the 2026 ACC/AHA Dyslipidemia Guidelines into real-world, patient-centered practice — including LDL-C targets, Lp(a), CAC, ApoB, and management of high-risk populations. Open to all. Complimentary. Tune in now 👇 🔗 aspconline.org/new-lipid-guid… #CardioCore #LipidGuidelines #PreventiveCardiology #CardiologyEducation #ASPC

ASPC@ASPCardio

⏰ Happening THIS Wednesday! CardioCore: Lipid Guidelines 📅 May 13, 2026 | 6:00–7:00 PM EDT 🎓 Lecturer: @rblument1 Join ASPC for a FREE webinar translating the 2026 ACC/AHA Dyslipidemia Guidelines into real-world, patient-centered practice — covering LDL-C targets, Lp(a), CAC, ApoB, and high-risk populations. Open to all. Complimentary. Don't miss it. 👇 🔗 aspconline.org/new-lipid-guid… #CardioCore #LipidGuidelines #PreventiveCardiology #CardiologyEducation #ASPC

English

0

3

356

ASPC retweetledi

NYU CVD Prevention@NYUCVDPrevent·13 May

📣New in AJPC: AHA #Lipoprotein(a) Discovery Project Congrats to Dr. Howard Weintraub and colleagues on this publication! This 3 year project was instrumental in developing foundational clinician & patient education resources to advance #LPA awareness. sciencedirect.com/science/articl…

English

0

8

13

1.3K

ASPC@ASPCardio·11 May

⏰ Happening THIS Wednesday! CardioCore: Lipid Guidelines 📅 May 13, 2026 | 6:00–7:00 PM EDT 🎓 Lecturer: @rblument1 Join ASPC for a FREE webinar translating the 2026 ACC/AHA Dyslipidemia Guidelines into real-world, patient-centered practice — covering LDL-C targets, Lp(a), CAC, ApoB, and high-risk populations. Open to all. Complimentary. Don't miss it. 👇 🔗 aspconline.org/new-lipid-guid… #CardioCore #LipidGuidelines #PreventiveCardiology #CardiologyEducation #ASPC

ASPC@ASPCardio

CardioCore: Foundational Lectures in Cardiovascular Disease Prevention — a monthly webinar series from ASPC designed to deliver high-quality preventive cardiology education to trainees and clinicians. Complimentary and open to all, with sessions led by experts in the field. 📅 Lipid Guidelines 🗓 Wednesday, May 13, 2026 ⏰ 6:00–7:00 PM EDT 🎤 Lecturer: @rblument1 This session will translate the 2026 ACC/AHA Multi-Society Dyslipidemia Guideline into practical, patient-centered care, including: • Assessing cardiovascular risk using contemporary tools • Initiating and intensifying lipid-lowering therapy based on individualized risk • Applying updated treatment targets (LDL-C, non–HDL-C, ApoB) Additional topics: • Incorporating risk markers such as Lp(a) and coronary artery calcium • Triglyceride management in ASCVD and pancreatitis risk • Evidence-based strategies for high-risk populations, including diabetes and chronic kidney disease Register: aspconline.org/new-lipid-guid… #CardioCore #PreventiveCardiology #CardiologyEducation #LipidGuidelines #ASPC

English

0

5

11

1.8K

ASPC retweetledi

Charles German@DrGermanMD·11 May

Don't miss out on our upcoming Obesity Next CME 5/14/2026, I will be speaking on CVD Risk Assessment in light of the 2026 Cholesterol Guidelines

English

1

5

156

ASPC retweetledi

AJPC@AJPCardio·9 May

New research highlights the powerful role nutrition can play in early hypertension management. A higher adherence to the DASH eating pattern may help delay or reduce the need for medication initiation in adults with stage 1 hypertension. The findings reinforce what many clinicians already see in practice: lifestyle interventions aren’t just complementary—they can be foundational. The DASH diet emphasizes: 🥗 Fruits & vegetables 🌾 Whole grains 🥛 Low-fat dairy 🐟 Lean proteins 🧂 Reduced sodium intake As rates of hypertension continue to rise, evidence-based nutrition strategies could have a major impact on long-term cardiovascular health and healthcare costs. Read it here: sciencedirect.com/science/articl…

English

2

10

33

8.6K

ASPC retweetledi

AJPC@AJPCardio·9 May

🔬 New research: Can a blood protein panel predict heart failure in people with fatty liver disease — years before it happens? A new prospective cohort study of 17,091 individuals with MASLD (metabolic dysfunction-associated steatotic liver disease) found that large-scale plasma proteomics dramatically improves heart failure risk prediction beyond standard clinical tools. Key findings: → 953 heart failure events recorded over a median 13.56-year follow-up → A 37-protein panel boosted predictive accuracy from a C-index of 0.723 to 0.805 — a meaningful leap beyond the AHA's PREVENT clinical model → Just 5 proteins (NT-proBNP, WFDC2, LTBP2, BCAN, HAVCR1) captured most of that gain, offering a practical, clinic-ready tool → At a 10-year horizon, the combined model identified 3.3 additional true heart failure cases per 1,000 patients — without more false alarms Why it matters: MASLD affects roughly 1 in 4 people globally and raises heart failure risk through inflammation, fat deposition, and organ fibrosis — pathways that standard risk calculators largely miss. This proteomic signature reflects that multi-organ biology, linking liver, kidney, and cardiac stress into a single actionable panel. The liver–heart axis is real. Proteomics may be the key to catching it early. sciencedirect.com/science/articl… #Cardiology #MASLD #HeartFailure #Proteomics #PrecisionMedicine #Biomarkers #CardiovascularResearch

English

0

7

15

1.4K

ASPC@ASPCardio·10 May

🩺 Happy #NationalLipidDay! What better way to celebrate than with a brand-new podcast episode dropping TODAY? Episode: The 2026 Dyslipidemia Guidelines Playbook: From Evidence to Action Join host @Kpakanati3 for an in-depth discussion with co-chair of the guidelines @rblument1 and committee member @tygluckman as they break down the highly anticipated 2026 ACC/AHA/Multisociety Dyslipidemia Guidelines. In this episode, explore the biggest updates shaping lipid management today, including LDL-C targets, the PREVENT risk score, coronary artery calcium (CAC), Lp(a), apoB, and the evolving role of personalized risk assessment. The conversation also dives into practical strategies for applying the guidelines in real-world clinical practice, navigating treatment barriers, and improving long-term cardiovascular prevention. Listeners will gain expert insight into: • Key changes in the 2026 dyslipidemia guidelines • Treat-to-target vs. threshold-based therapy • Risk stratification using PREVENT, CAC, Lp(a), and apoB • Lipid management in women and younger patients • Cost, access, adherence, and emerging therapies • The future of preventive cardiology and systems-based care A must-listen episode for clinicians, trainees, and anyone passionate about advancing cardiovascular prevention. 🗓 Available now — Sunday, May 10, 2026 | National Lipid Day art19.com/shows/the-hear… #NationalLipidDay #HeartOfPrevention #PreventiveCardiology #Dyslipidemia #CardiologyPodcast #ASPC #LipidManagement @AJPCardio

English

0

3

12

556

ASPC retweetledi

Dr. Martha Gulati ♥️🫀❤️‍🩹🇨🇦@DrMarthaGulati·9 May

Nice work by @DrOstfeld et al! Lifestyle especially diet should always be prescribed for all #Hypertension @ASPCardio @AJPCardio @khurramn1

AJPC@AJPCardio

New research highlights the powerful role nutrition can play in early hypertension management. A higher adherence to the DASH eating pattern may help delay or reduce the need for medication initiation in adults with stage 1 hypertension. The findings reinforce what many clinicians already see in practice: lifestyle interventions aren’t just complementary—they can be foundational. The DASH diet emphasizes: 🥗 Fruits & vegetables 🌾 Whole grains 🥛 Low-fat dairy 🐟 Lean proteins 🧂 Reduced sodium intake As rates of hypertension continue to rise, evidence-based nutrition strategies could have a major impact on long-term cardiovascular health and healthcare costs. Read it here: sciencedirect.com/science/articl…

English

2

8

33

4.9K

ASPC retweetledi

Michael D. Shapiro@DrMichaelShapir·8 May

Not be missed !

ASPC@ASPCardio

🎙️ New episode dropping May 10 — on #NationalLipidDay! The Heart of Prevention | ASPC Official Podcast 📌 The 2026 Dyslipidemia Guidelines Playbook: From Evidence to Action Host @Kpakanati3 sits down with two titans of preventive cardiology — @rblument1 & @tygluckman — to unpack the landmark 2026 ACC/AHA/Multisociety Dyslipidemia Guidelines. What's covered: 🔹 LDL-C targets & treat-to-target vs. threshold-based therapy 🔹 PREVENT risk score, CAC, Lp(a), and apoB in risk stratification 🔹 Lipid management in women & younger patients 🔹 Cost, access, adherence & emerging therapies 🔹 The future of systems-based cardiovascular prevention Whether you're a clinician, trainee, or prevention champion — this one is essential listening. 🗓️ Launches May 10, 2026 | #NationalLipidDay Subscribe: art19.com/shows/the-hear… #HeartOfPrevention #PreventiveCardiology #Dyslipidemia #CardiologyPodcast #ASPC #LipidManagement

English

0

5

12

1.3K

ASPC@ASPCardio·8 May

🎙️ New episode dropping May 10 — on #NationalLipidDay! The Heart of Prevention | ASPC Official Podcast 📌 The 2026 Dyslipidemia Guidelines Playbook: From Evidence to Action Host @Kpakanati3 sits down with two titans of preventive cardiology — @rblument1 & @tygluckman — to unpack the landmark 2026 ACC/AHA/Multisociety Dyslipidemia Guidelines. What's covered: 🔹 LDL-C targets & treat-to-target vs. threshold-based therapy 🔹 PREVENT risk score, CAC, Lp(a), and apoB in risk stratification 🔹 Lipid management in women & younger patients 🔹 Cost, access, adherence & emerging therapies 🔹 The future of systems-based cardiovascular prevention Whether you're a clinician, trainee, or prevention champion — this one is essential listening. 🗓️ Launches May 10, 2026 | #NationalLipidDay Subscribe: art19.com/shows/the-hear… #HeartOfPrevention #PreventiveCardiology #Dyslipidemia #CardiologyPodcast #ASPC #LipidManagement

English

1

7

12

1.9K

ASPC retweetledi

JaredSpitzMD@JSpitz_MD·7 May

Amazing call for action! @AnaBaracCardio @BrazileTiffany @ISHVnews @ASPCardio

AJPC@AJPCardio

📄 New Research Spotlight Blueprint for Adapting Cardiac Rehabilitation for Oncology Patients with Cardiovascular-Kidney-Metabolic (CKM) Syndrome As cancer survivorship grows, so does the complexity of managing overlapping cardiovascular, kidney, and metabolic disease. CKM syndrome represents an interconnected burden that worsens outcomes and requires a more integrated care model. This new work explores how the proven cardiac rehabilitation model can be adapted for oncology patients—offering a structured, multidisciplinary approach to improve functional capacity, quality of life, and long-term outcomes. Exercise-based rehab has already shown benefits in cancer populations, including improved strength and overall well-being. 🔍 Key takeaway: The future of cardio-oncology care lies in personalized, rehab-driven strategies that address the full cardiometabolic spectrum—not just cancer alone. 📖 Read more: sciencedirect.com/science/articl… #CardioOncology #CardiacRehab #CKMSyndrome #CancerCare #PreventiveCardiology

English

1

6

11

1.4K

ASPC retweetledi

AJPC@AJPCardio·3 May

📊 New Research Alert How do BMI and waist-to-height ratio shape heart failure risk in adults <45? In a large U.S. cohort (~89K), both extremes of BMI (underweight & severe obesity) and central adiposity (WHtR ≥0.5) were linked to higher early-onset HF risk—especially HFpEF. 💡 Key takeaway: BMI alone isn’t enough—fat distribution matters for risk stratification. 🔗 Read more: sciencedirect.com/science/articl… #Cardiology #HeartFailure #Obesity #Prevention #PublicHealth

English

1

3

8

710

ASPC retweetledi

Dr. Martha Gulati ♥️🫀❤️‍🩹🇨🇦@DrMarthaGulati·3 May

Thank you to @WomenAs1 for sharing our important editorial in @AJPCardio @ASPCardio @Nishant_ShahMD @khurramn1 Inclusion of #women in clinic trials is essential to treat the entire population

Women As One@WomenAs1

Representation is prevention. Women still receive less preventive care, face delays, and have higher relative risk from the same conditions. Without representation in trials, we miss critical insights. Better data means better, more equitable care. sciencedirect.com/science/articl…

English

1

14

34

3.9K

ASPC@ASPCardio·1 May

Now available on demand: ASPC 2026 Virtual Imaging Symposium Multimodality Cardiovascular Imaging for Prevention: Essential Insights for Clinicians Missed the live event? You can now access this expert-led half-day program anytime. Originally held on April 25, 2026, this virtual symposium brings together leading voices in preventive cardiology to deliver practical, evidence-based insights on the use of advanced, non-invasive imaging in clinical practice. 🔍 What you’ll gain: • Strategies for early detection of cardiovascular disease • Tools for more precise risk stratification • Guidance on imaging-driven clinical decision-making • Approaches to optimize patient management Featured speakers include: @CardioMDPhD Leandro Slipczuk, MD, PhD, FASPC, @a_l_bailey Alison Bailey, MD, FASPC, @MichaelJBlaha Michael Blaha, MD, MPH, @khurramn1 Khurram Nasir, MD, MPH, MSc, FASPC, Parag Joshi, MD, MHS, @lesleejshaw Leslee Shaw, PhD, Matthew Budoff, MD, @DLBHATTMD Deepak L. Bhatt, MD, MPH, FASPC, Seamus Whelton, MD, MPH, Valentin Fuster, MD, PhD, @Borjaibanez1 Borja Ibanez, MD, PhD, Beatriz López-Melgar, MD, PhD, Harold Bays, MD, FASPC, Salvatore Carbone, PhD, RDN, @DonnaRyanMD Donna H. Ryan, MD Unrestricted educational support for the program is provided by industry partners @Heartflow and @Cleerlyhealth 📺 Watch on demand: youtube.com/watch?v=t341F4… #Cardiology #PreventiveCardiology #MedicalEducation #CardiovascularImaging #ASPC @AJPCardio

YouTube

English

0

8

18

861

ASPC

Keşfet